Characterization of tick-borne encephalitis virus-specific human T lymphocyte responses by stimulation with structural TBEV proteins expressed in a recombinant baculovirus

Viral Immunology

Volumn 16, Issue 3, 2003, Pages 407-414

  Gomez, I ^a   Marx, F ^b   Saurwein Teissl, M ^a   Gould, E A ^c   Grubeck Loebenstein, Beatrix ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; RECOMBINANT C PROTEIN; RECOMBINANT E PROTEIN; RECOMBINANT NS3 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; BACULOVIRUS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INSECT CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINATION; VIRUS RECOMBINANT;

ACARI; FLAVIVIRUS; INSECTA; RNA VIRUSES; TICK-BORNE ENCEPHALITIS VIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0141925620     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403322396190     Document Type: Article

References (22)

1. Aberle, J.H., S.W. Allison, S.L. Stiasny, et al. 1999. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J. Immunol. 163:6756-6761.
2. Aihara, H., T. Takasaki, T. Toyosaki-Maeda, et al. 2000. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine. Viral Immunol. 13:179-186.
3. Chambers, T.J., C.S. Hahn, R. Galler, et al. 1990. Flavivirus genome organization, expression and replication. Annu. Rev. Microbiol. 44:649-688.
4. Gould, E.A., A., Buckley, A.D.T. Barrett, et al. 1986. Neutralizing (54-kilodalton) and non-neutralizing (54-kilodalton and 48-kilodalton) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J. Gen. Virol. 67:591-595.
5. Gritsun, T.S., A. Desai, and E.A. Gould. 2001. The degree of attenuation of tick-borne encephalitis virus depends on the cumulative effects of point mutations. J. Gen. Virol. 82:1667-1675.
6. Heinz, F.X. 1986. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:103-168.
7. Janeway, C.A., P. Travers, M. Walport, et al. 2001. T cell-mediated immunity, pp. 323-324. In: D. Schanck, P. Austin, and E. Lawrence (eds.), Immunobiology, 5th ed. Garland Publishing. New York.
8. Khozinsky, V.V., and B.F. Semenov. 1986. H-2 restricted regulation by soluble autoantigens of the tick-borne encephalitis virus-induced autoreactive T-effector and T-suppressor lymphocytes in mice. Acta Virol. 30:35-44.
9. King, L.A., and R.D. Possee. 1992. The Baculovirus Expression System: A Laboratory Guide, 1st ed. London: Chapman and Hall.
10. Kofler, R.M., F.X. Heinz, and C.W. Mandl. 2002. Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J. Virol. 76:3534-3543.
11. Konishi, E., I. Kurane, P.W. Mason, et al. 1995. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am. J. Trop. Med. Hyg. 53:278-283.
12. Kunz, C. 2003. TBE vaccination and the Austrian experience. Vaccine 1:21:S50-S55.
13. - cytotoxic T-cell clone. J. Virol. 67:6285-6288.
14. Marx, F., T.S. Gritsun, B. Grubeck-Loebenstein, et al. 2001. Diagnostic immunoassays for tick-borne encephalitis virus based on recombinant baculovirus protein expression. J. Virol. Methods 91:75-84.
15. Matsuura, Y., M. Miyamoto, T. Sato, et al. 1989. Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses. Virology 173:674-682.
16. Pletnev, A.G., M. Bray, K.A. Hanley, et al. 2001. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. J. Virol. 75:8259-8267.
17. Schlesinger, J.J., M.W. Brandriss, and E.E. Walsh. 1985. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol. 135:2805-2809.
18. + T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J. Virol. 73:398-403.
19. Stiasny, K., S.L. Allison, A. Marchler-Bauer, et al. 1996. Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J. Virol. 70:8142-8147.
20. Venugopal, K., and E.A. Gould. 1994. Towards a new generation of flavivirus vaccines. Vaccine 12:966-975.
21. Vlak, J.M., and R.J. Keus. 1990. Baculovirus expression vector system for production of viral vaccines. Adv. Biotechnol. Proc. 14:91-128.
22. Zivna, I., S. Green, D.W. Vaughn, et al. 2002. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 168:5959-5965.